Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
Add more filters










Publication year range
1.
Radiat Res ; 158(1): 110-4, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12071810

ABSTRACT

The ability of the aminothiol WR-1065 [N-(2-mercaptoethyl)-1,3-diaminopropane] to protect L5178Y (LY) cells against the cytotoxic and mutagenic effects of exposure to accelerated (56)Fe ions (1.08 GeV/nucleon) was determined. It was found that while WR-1065 reduced the mutagenicity in both cell lines when it was present during the irradiation, the addition of WR-1065 after the exposure had no effect on the mutagenicity of the radiation in either cell line. No marked protection against the cytotoxic effects of exposure to (56)Fe ions was provided by WR-1065 when added either during or after irradiation in either cell line. We reported previously that WR-1065 protected the LY-S1 and LY-SR1 cell lines against both the cytotoxicity and mutagenicity of X radiation when present during exposure, but that its protection when administered after exposure was limited to the mutagenic effects in the radiation-hypersensitive cell line, LY-S1. The results indicate that the mechanisms involved differ in the protection against cytotoxic compared to mutagenic effects and in the protection against damage caused by accelerated (56)Fe ions compared to X radiation.


Subject(s)
Antimutagenic Agents/pharmacology , Iron Radioisotopes/pharmacology , Leukemia L5178/genetics , Mercaptoethylamines/pharmacology , Mutation/drug effects , Radiation-Protective Agents/pharmacology , Animals , DNA/drug effects , Tumor Cells, Cultured
2.
Cancer Genet Cytogenet ; 129(2): 124-30, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11566342

ABSTRACT

The characteristics of spontaneous and radiation-induced chromosome instability were determined in each of 50 individual clones isolated from control populations of human lymphoblasts (WTK1), as well as from populations of these cells previously exposed to two different types of ionizing radiation, Fe-56 and Cs-137. The types of chromosome instability did not appear to change in clones surviving radiation exposure. Aneuploidy, polyploidy, chromosome dicentrics and translocations, and chromatid breaks and gaps were found in both control and irradiated clones. The primary effect of radiation exposure was to increase the number of cells within any one clone that had chromosome alterations. Chromosome instability was associated with telomere shortening and elevated levels of apoptosis. The results suggest that the proximal cause of chromosome instability is telomere shortening.


Subject(s)
Chromosomes/genetics , Chromosomes/radiation effects , Gamma Rays , Lymphocytes/cytology , Lymphocytes/radiation effects , Aneuploidy , Apoptosis/radiation effects , Cell Line , Chromatids/pathology , Chromatids/radiation effects , Chromosome Aberrations , Chromosome Disorders , Clone Cells/pathology , Clone Cells/radiation effects , Humans , Telomere/genetics , Translocation, Genetic/genetics
3.
Radiat Res ; 156(3): 259-71, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11500135

ABSTRACT

To obtain information on the origin of radiation-induced genomic instability, we characterized a total of 166 clones that survived exposure to (56)Fe particles or (137)Cs gamma radiation, isolated approximately 36 generations after exposure, along with their respective control clones. Cytogenetic aberrations, growth alterations, responses to a second irradiation, and mutant frequencies at the Na(+)/K(+) ATPase and thymidine kinase loci were determined. A greater percentage of clones that survived exposure to (56)Fe particles exhibited instability (defined as clones showing one or more outlying characteristics) than in the case of those that survived gamma irradiation. The phenotypes of the unstable clones that survived exposure to (56)Fe particles were also qualitatively different from those of the clones that survived gamma irradiation. A greater percentage (20%) of the unstable clones that survived gamma irradiation than those that survived exposure to (56)Fe particles (4%) showed an altered response to the second irradiation, while an increase in the percentage of clones that had an outlying frequency of ouabain-resistant and thymidine kinase mutants was more evident in the clones exposed to (56)Fe particles than in those exposed to gamma rays. Growth alterations and increases in dicentric chromosomes were found only in clones with more than one alteration. These results underscore the complex nature of genomic instability and the likelihood that radiation-induced genomic instability arises from different original events.


Subject(s)
Cesium Radioisotopes , Iron Isotopes , Lymphocytes/radiation effects , Apoptosis , Chromosome Aberrations , Clone Cells , Humans , Linear Energy Transfer , Lymphocytes/enzymology , Mutation , Sodium-Potassium-Exchanging ATPase/genetics , Thymidine Kinase/genetics
4.
Radiat Res ; 156(2): 186-94, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11448240

ABSTRACT

The effects of (56)Fe particles and (137)Cs gamma radiation were compared in TK6 and WTK1 human lymphoblasts, two related cell lines which differ in TP53 status and in the ability to rejoin DNA double-strand breaks. Both cell lines were more sensitive to the cytotoxic and clastogenic effects of (56)Fe particles than to those of gamma rays. However, the mutagenicity of (56)Fe particles and gamma rays at the TK locus was the same per unit dose and was higher for gamma rays than for (56)Fe particles at isotoxic doses. The respective RBEs for TK6 and WTK1 cells were 1.5 and 1.9 for cytotoxicity and 2.5 and 1.9 for clastogenicity, but only 1 for mutagenicity. The results indicate that complex lesions induced by (56)Fe particles are repaired less efficiently than gamma-ray-induced lesions, leading to fewer colony-forming cells, a slightly higher proportion of aberrant cells at the first division, and a lower frequency of viable mutants at isotoxic doses. WTK1 cells (mutant TP53) were more resistant to the cytotoxic effects of both gamma rays and (56)Fe particles, but showed greater cytogenetic and mutagenic damage than TK6 cells (TP53(+)). A deficiency in the number of damaged TK6 cells (a) reaching the first mitosis after exposure and (b) forming viable mutants can explain these results.


Subject(s)
Iron/toxicity , Lymphocytes/radiation effects , Mutagens/toxicity , Cell Line , Cell Survival/radiation effects , Cesium Radioisotopes/toxicity , Chromosome Aberrations , DNA Damage , DNA Repair/genetics , Gamma Rays/adverse effects , Genes, p53 , Humans , Linear Energy Transfer , Lymphocytes/cytology , Lymphocytes/metabolism , Mutation , Radiation Tolerance
5.
Cancer Lett ; 165(1): 51-8, 2001 Apr 10.
Article in English | MEDLINE | ID: mdl-11248418

ABSTRACT

Photodynamic therapy (PDT) activates the mitochondrial pathway of apoptosis, for which the release of cytochrome c into the cytosol is considered critical. To further elucidate the role of cytochrome c release in PDT-induced apoptosis, we monitored cytochrome c localization immunocytochemically and related it to nuclear apoptosis of the same cells. When mouse L5178Y-R cells were treated with 300 nM phthalocyanine (Pc) 4 and 0-75 mJ/cm(2) red light, cytochrome c release had a dose response similar to that of clonogenic cell killing, with nearly identical threshold doses. Within individual cells, the release of cytochrome c appeared to be an all-or-none phenomenon. Moreover, it was tightly associated with activation of a caspase-3-like protease and changes in nuclear morphology. Thus, in response to Pc 4-PDT, the release of cytochrome c from mitochondria is a key determinant of apoptotic cell death.


Subject(s)
Apoptosis , Cytochrome c Group/metabolism , Indoles/pharmacology , Leukemia L5178/pathology , Photosensitizing Agents/pharmacology , Animals , Caspase 3 , Caspases/drug effects , Caspases/metabolism , Cell Survival/drug effects , Dose-Response Relationship, Drug , Enzyme Activation , Immunohistochemistry , Mice , Photochemotherapy , Subcellular Fractions/drug effects , Time Factors , Tumor Cells, Cultured , Tumor Stem Cell Assay
6.
Genes Chromosomes Cancer ; 30(3): 236-44, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11170280

ABSTRACT

Telomere shortening in telomerase-negative somatic cells leads to the activation of the TP53 protein and the elimination of potentially unstable cells. We examined the effect of TP53 gene expression on both telomere metabolism and chromosome stability in immortal, telomerase-positive cell lines. Telomere length, telomerase activity, and chromosome instability were measured in multiple clones isolated from three related human B-lymphoblast cell lines that vary in TP53 expression; TK6 cells express wild-type TP53, WTK1 cells overexpress a mutant form of TP53, and NH32 cells express no TP53 protein. Clonal variations in both telomere length and chromosome stability were observed, and shorter telomeres were associated with higher levels of chromosome instability. The shortest telomeres were found in WTK1- and NH32-derived cells, and these cells had 5- to 10-fold higher levels of chromosome instability. The primary marker of instability was the presence of dicentric chromosomes. Aneuploidy and other stable chromosome alterations were also found in clones showing high levels of dicentrics. Polyploidy was found only in WTK1-derived cells. Both telomere length and chromosome instability fluctuated in the different cell populations with time in culture, presumably as unstable cells and cells with short telomeres were eliminated from the growing population. Our results suggest that transient reductions in telomere lengths may be common in immortal cell lines and that these alterations in telomere metabolism can have a profound effect on chromosome stability.


Subject(s)
Cell Line, Transformed/enzymology , Chromosome Aberrations , Genes, p53/genetics , Telomerase/biosynthesis , Telomere/genetics , Clone Cells , DNA Replication/genetics , Gene Expression Regulation, Neoplastic/genetics , Humans , Mutation , Telomerase/metabolism , Tumor Cells, Cultured/enzymology
7.
Mutat Res ; 437(2): 135-50, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10556618

ABSTRACT

Ionizing radiation was the first mutagen discovered and was used to develop the first mutagenicity assay. In the ensuing 70+ years, ionizing radiation became a fundamental tool in understanding mutagenesis and is still a subject of intensive research. Frederick de Serres et al. developed and used the Neurospora crassa ad-3 system initially to explore the mutagenic effects of ionizing radiation. Using this system, de Serres et al. demonstrated the dependence of the frequency and spectra of mutations induced by ionizing radiation on the dose, dose rate, radiation quality, repair capabilities of the cells, and the target gene employed. This work in Neurospora predicted the subsequent observations of the mutagenic effects of ionizing radiation in mammalian cells. Modeled originally on the mouse specific-locus system developed by William L. Russell, the N. crassa ad-3 system developed by de Serres has itself served as a model for interpreting the results in subsequent systems in mammalian cells. This review describes the primary findings on the nature of ionizing radiation-induced mutagenesis in the N. crassa ad-3 system and the parallel observations made years later in mammalian cells.


Subject(s)
Mutagenesis , Neurospora crassa/genetics , Neurospora crassa/radiation effects , Animals , Bacteriophage T4/genetics , Base Sequence , DNA Repair/genetics , DNA, Viral/genetics , Dose-Response Relationship, Radiation , Genes, Fungal/radiation effects , Genetics, Microbial/history , History, 20th Century , Humans , Molecular Sequence Data
8.
Radiat Res ; 151(4): 391-7, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10190490

ABSTRACT

The purpose of this study was to determine the antimutagenicity of WR-1065 added after irradiation of cells of cell lines differing in their ability to rejoin radiation-induced DNA double-strand breaks (DSBs). The postirradiation antimutagenicity of WR-1065 at the thymidine kinase locus was demonstrated for L5178Y (LY)-S1 cells that are deficient in repair of DNA DSBs. Less postirradiation antimutagenicity of WR-1065 was observed in LY-R16 and LY-SR1 cells, which are relatively efficient in DSB repair. Postirradiation treatment with WR-1065 had only a small stimulatory effect on DSB rejoining. A 3-h incubation of irradiated LY cells with WR-1065 caused slight changes in the distribution of cells in the phases of the cell cycle that differed between LY-S1 and LY-SR1 cells. Both LY-S1 and LY-SR1 cells were protected against the cytotoxic and mutagenic effects of radiation when WR-1065 was present 30 min before and during the irradiation. We conclude that the differential postirradiation effects of WR-1065 in the LY-S1 and LY-SR1 cells are not caused by differences in cellular uptake of the radioprotector or in its radical scavenging activity. Possible mechanisms for the postirradiation antimutagenicity of WR-1065 are discussed.


Subject(s)
Antimutagenic Agents/pharmacology , DNA/radiation effects , Leukemia L5178/genetics , Mercaptoethylamines/pharmacology , Animals , DNA Repair/drug effects , Mice , Mice, Inbred DBA , Thymidine Kinase/genetics , Tumor Cells, Cultured
9.
Biotechniques ; 26(3): 532-4, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10090996

ABSTRACT

Chromosome aberrations are a sensitive indicator of genetic change, and the measurement of chromosome aberration frequency in peripheral blood lymphocytes is often used as a biological dosimeter of exposure (1,4). The length of time that cells are maintained in culture before cytogenetic analysis is probably the most important in vitro factor that influences both the frequency and types of aberrations that are seen following exposure to mutagens. Therefore, for accurate cytogenetic measurements of genetic damage, cells must be analyzed in their first mitosis following exposure. As cells progress through subsequent mitotic division cycles, cells with unstable types of aberrations, e.g., dicentrics and acentric fragments, are eliminated (1,3,4). Even the use of synchronized populations of cells does not guarantee that all cells analyzed will be in their first division following treatment. Small variations in growth rate after irradiation can lead to large variations in the proportion of cells that are in their first vs. a subsequent mitosis. For example, 48 h after G0 lymphocytes are stimulated to enter the cell cycle (the standard sampling time for cytogenetic analysis), up to 50% of the cells in mitosis can be in their second division cycle (10). While there are methods available to distinguish cells in different division cycles (see Introduction), they are not easily adapted for use with standard fluorescence in situ hybridization (FISH) procedures. The goal of this study was to develop a simple approach to detect aberrations by FISH whereby cells in different division cycles could be distinguished.


Subject(s)
Chromosome Aberrations , In Situ Hybridization, Fluorescence/methods , Cell Cycle , Cell Division , Cell Line , Centromere/genetics , Chromosomes, Human, Pair 2/genetics , Humans , Lymphocytes/metabolism , Staining and Labeling
10.
Radiat Res ; 150(5 Suppl): S146-56, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9806617

ABSTRACT

Photodynamic therapy (PDT) is dependent on the uptake of a photosensitizing dye, often a porphyrin-related macrocycle, by the tumor or other abnormal tissue that is to be treated, the subsequent irradiation of the tumor with visible light of an appropriate wavelength matched to the absorption spectrum of the dye, and molecular oxygen to generate reactive oxygen intermediates. The initial oxidative reactions lead to damage to organelles in which the dye is bound, culminating in cell death and destruction of the tumor or abnormal tissue. Apoptosis is a common mechanism of cell death after PDT both in vitro and in vivo. PDT also triggers the activation of several signal transduction pathways in the treated cells; some of these are stress responses aimed at cell protection, while others are likely to contribute to the cell death process. The photosensitizers of greatest interest in PDT bind to various cytoplasmic membranes but are not found in the nucleus and do not bind to DNA. Nevertheless, some DNA damage is produced that can lead to mutagenesis, the extent of which is dependent on the photosensitizer, the cellular repair properties and the target gene. Thus, in spite of generating some responses common to ionizing radiation and other oxidative stresses, PDT is unique in the subcellular localization of damage, the combination of signaling pathways that are activated, and rapid kinetics of the induction of cell death processes.


Subject(s)
Photochemotherapy , Animals , Apoptosis , Humans , Neoplasms/drug therapy , Neoplasms/pathology , Photochemistry , Photosensitizing Agents/pharmacokinetics , Photosensitizing Agents/therapeutic use , Signal Transduction , Tissue Distribution
11.
Photochem Photobiol ; 67(6): 720-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9648537

ABSTRACT

A decrease in the efficacy of photodynamic therapy (PDT) with phthalocyanine photosensitizers was observed for lymphoblastic murine and human cell lines as the time between the addition of the photosensitizer, aluminum phthalocyanine (AIPc), to the culture medium and exposure to light was increased from 4 h to 18 h. The total intracellular concentration of photosensitizer did not decrease significantly during this 18 h interval. For the murine cell lines, the maximum cytotoxic and mutagenic effects were observed when the time between addition of the photosensitizer and irradiation was between 1 and 4 h. The time course of the variations in efficacy did not vary greatly from one murine cell line to another, even though the cell lines differ markedly in the extent of their cytotoxic and mutagenic response. The time course of the variation was similar for cytotoxicity and mutagenicity, as well as for the induction of DNA fragmentation. The human lymphoblastic cell line, WTK1, showed less variation in survival and mutability with time than did the murine cell lines. With Pc 4 (HOSiPcOSi[CH3]2[CH2]3N[CH3]2) as the photosensitizer, the photocytotoxicity for murine L5178Y (LY)-S1 cells did not change significantly as the time between addition of Pc 4 and irradiation was increased from 2 to 18 h. However, the mutagenicity decreased by a factor of three during this interval. The mutagenicity of PDT with Pc 4 was much less in LY-S1 cells than that with AlPc. The results suggest that the variation in the efficacy observed for AlPc-induced photocytotoxicity is caused by changes in the intracellular distribution and/or the aggregation of the photosensitizer with time after its addition.


Subject(s)
Indoles/pharmacokinetics , Indoles/toxicity , Organometallic Compounds/pharmacokinetics , Organometallic Compounds/toxicity , Organosilicon Compounds/pharmacokinetics , Organosilicon Compounds/toxicity , Photosensitizing Agents/pharmacokinetics , Photosensitizing Agents/toxicity , Silanes , Aluminum/pharmacokinetics , Aluminum/toxicity , Animals , B-Lymphocytes , Biological Transport , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Humans , Leukemia L5178 , Light , Mice , Mice, Inbred DBA , Tumor Cells, Cultured , X-Rays
12.
Acad Med ; 72(8): 688-92, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9282143

ABSTRACT

Price competition and other aspects of the changing health care environment are threatening many academic health centers (AHCs) and causing them to reassess their education and research missions. In order to design effective AHCs for the next century, medical leaders must define the unique competencies needed by tomorrow's physicians and describe the educational enterprises required to produce physicians with these competencies. Two of the most important of these competencies are the ability to manage the uncertainty associated with creating clinical paradigms and the ability to manage the uncertainty associated with managing care delivery. Creating clinical paradigms involves (1) developing knowledge about disease categories and (2) developing knowledge about the most appropriate therapy for a disease in a particular category. Both these tasks involve uncertainty. The second type of uncertainty is associated with managing care delivery and is largely a matter of optimizing current clinical paradigms. The challenges are (1) to correctly assign patients' diseases to existing disease categories, and (2) to correctly choose and manage the delivery of the most appropriate therapies to these patients. Currently, AHCs are more competent in managing--and educating students to manage--the uncertainty involved in creating clinical paradigms. But there is an increasing demand for physicians who manage the second type of uncertainty associated with care delivery. The authors conclude that in order to remain viable, AHCs, and particularly their medical schools, must broaden their educational goals so that students can learn to manage both forms of uncertainty.


Subject(s)
Delivery of Health Care , Education, Medical/methods , Academic Medical Centers , Diagnosis , Students, Medical , Therapeutics , United States
13.
Photochem Photobiol ; 66(5): 690-6, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9383992

ABSTRACT

The mutagenicity of photodynamic therapy (PDT) using red light and either Photofrin (porfimer sodium) (PF) or aluminum phthalocyanine (AlPc) as the photosensitizer was determined at the thymidine kinase (TK) locus in the human lymphoblastic cell lines, TK6 and WTK1, and was compared to the mutagenicity of UVC and X-radiation in these cells as well as the mutagenicity of PDT in murine L5178Y lymphoblastic cell lines. Photodynamic therapy was found not to be mutagenic in TK6 cells, which possess an active p53 gene and which are relatively deficient in recombination and repair of DNA double-strand breaks. In contrast, PDT with either sensitizer was significantly mutagenic in WTK1 cells, which harbor an inactivating mutation in the p53 gene and are relatively efficient in recombination and double-strand break repair as compared to TK6 cells. The induced mutant frequency in WTK1 cells with PF as the photosensitizer was similar to that induced by UVC radiation but lower than that induced by X-radiation at equitoxic fluences/doses. The mutant frequency induced by PDT in WTK1 cells with either photosensitizer was much lower than that induced in murine lymphoblasts at equitoxic fluences. The TK6 and WTK1 cells did not differ in their sensitivity to the cytotoxic effects of PDT, but the level of PDT-induced apoptosis was greater in TK6 than in WTK1 cells. These results indicate that the mutagenicity of PDT varies in different types of cells and may be related to the repair capabilities as well as the p53 status of the cells.


Subject(s)
Mutation , Photochemotherapy/adverse effects , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Cell Line , DNA Damage , Humans , Lymphocytes/drug effects , Lymphocytes/radiation effects , Mice , Photobiology , Ultraviolet Rays/adverse effects , X-Rays
15.
Radiat Res ; 146(2): 131-8, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8693062

ABSTRACT

TK1+/- L5178Y-R16 cells were separated into G1, S and G2/M-phase populations by centrifugal elutriation and were treated with 1.5 Gy X radiation. Cells irradiated in the G1 and G2/M phases were most sensitive to the cytotoxic effects of radiation, while cells irradiated in the G2/M phase showed the highest mutant frequency at the thymidine kinase (Tk1) locus. DNA isolated from independent TK1-/- mutants was analyzed for loss of heterozygosity (LOH) at the Tk1 locus and two microsatellites, D11Mit48 and D11Nds7. Homogenates of each mutant were assayed for activity of galactokinase (GLK), the product of the galactokinase (Glk) gene neighboring the Tk1 gene on chromosome 11. Irradiated G1-phase cells had the highest percentage of mutants showing no LOH. The frequency of mutants with LOH at both Tk1 and D11Nds7 with no loss of GLK activity was high in all cell populations: There was no significant difference in the observed frequency of these mutants between the populations. The frequency of mutants losing GLK activity was low, particularly in cells irradiated in the S or G2/M phases. The possibility that the loss of GLK activity is not indicative of LOH at the Glk gene under the conditions of the present experiments is discussed.


Subject(s)
Leukemia L5178/genetics , Mutation , Thymidine Kinase/genetics , Animals , Base Sequence , Cell Cycle/radiation effects , Cell Survival/radiation effects , Chromosome Deletion , Chromosome Mapping , Galactokinase/metabolism , Mice , Mitosis , Molecular Sequence Data , Tumor Cells, Cultured , X-Rays
16.
Radiat Res ; 145(1): 31-8, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8532834

ABSTRACT

Human TK6 lymphoblasts were exposed to X radiation or radon, and thymidine kinase negative (TK-/-) mutants were selected, isolated and harvested for analysis of structural changes in the TK gene. A large majority (82%) of the radon-induced mutants, 74% of the X-radiation-induced mutants and 45% of the spontaneous mutants lost the entire active TK allele. To analyze these mutants further we measured the loss of heterozygosity at several loci neighboring the TK locus on chromosome 17q. A greater proportion (61%) of the radon-induced mutants than X-radiation-induced or spontaneous mutants harbored the smaller lesions involving the TK allele alone or extending from the TK locus to one or both of the closest neighboring sequences tested. Further, 21% of the X-radiation-induced mutants but only 5% of the radon-induced mutants lost heterozygosity at the col1A1 locus, 31 Mb from the TK gene. These results are in agreement with a recent analysis of radon- and X-radiation-induced lesions inactivating the HPRT gene of TK6 cells, in which we reported that a lower percentage of radon- than X-radiation-induced mutants showed lesions extending to markers 800 kb or more from the HPRT gene on the X chromosome (Bao et al., Mutat. Res. 326, 1-13, 1995). In the present study, we observed that the percentage of slowly growing and very slowly growing TK-/- mutants was greater after treatment with radon than after treatment with X radiation, regardless of the type of lesion present. It is possible, therefore, that the radon-induced lesions are complex and/or less easily repaired, leading to slow growth in a large proportion of the surviving mutant cells.


Subject(s)
Chromosome Aberrations , Chromosome Deletion , Chromosomes, Human, Pair 17 , Genes/radiation effects , Mutagenesis , Polymorphism, Restriction Fragment Length , Radon , Thymidine Kinase/genetics , B-Lymphocytes , Base Sequence , Blotting, Southern , Cell Line , Chromosome Mapping , Chromosomes, Human, Pair 17/radiation effects , DNA Primers , Dose-Response Relationship, Radiation , Humans , Molecular Sequence Data , Polymerase Chain Reaction , Thymidine Kinase/deficiency , X-Rays
17.
Mutat Res ; 326(1): 1-15, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7528877

ABSTRACT

Mutations caused by exposure to X-radiation and to radon and its decay products were compared in the hprt gene of a human lymphoblastoid cell line. Thirty-one X-radiation-induced, 29 radon-induced, and 24 spontaneous mutants were recovered from cell cultures under identical conditions except for the exposure to radiation. Seven spontaneous point mutations were recovered and DNA sequenced. These mutations included three C:G-->T:A transitions. These spontaneous point mutations were located in the exon or splice donor regions of five of the nine hprt exons. Four X-radiation-induced and three radon-induced point mutations were also analyzed by DNA sequencing. The frequency of induced mutants at the D0 doses for radon and X-radiation respectively were 5 x 10(-6) and 4.5 x 10(-6). Deletions were the predominant mutations recovered from both radon- and X-irradiated cells. Eighty-one percent of the mutants from X-radiation-treated cultures, 86% of the radon-treated cultures, and 63% of the spontaneous mutants involved deletions. Deletions involving exon and intron DNA, as well as intron DNA alone, were found to inactivate the hprt gene and result in a selectable HPRT- phenotype. Among the deletion mutants, however, only 21% of the spontaneous mutants versus 55% of both the X-radiation- and radon-induced mutants exhibited loss of the entire hprt gene. More X-radiation-induced deletions than radon-induced deletions extended further than 800 bp in the telomeric direction from the hprt gene (six of 17 versus two of 17). The results show that at the human hprt locus of TK-6 cells the predominant kind of mutation indicative of exposure to both high LET alpha-radiation and low LET X-radiation is a large deletion, spanning the entire hemizygous hprt gene and extending into flanking sequences.


Subject(s)
Alpha Particles , Gene Deletion , Hypoxanthine Phosphoribosyltransferase/genetics , Lymphocytes/enzymology , X-Rays , Base Sequence , Cell Line , Cell Survival , DNA , Humans , Lymphocytes/radiation effects , Molecular Sequence Data , Radon
18.
Radiat Res ; 140(3): 387-92, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7972692

ABSTRACT

Upon exposure of cells to radiation delivered at a continuous low dose rate, cell proliferation may be sustained with the cells exhibiting a constant doubling time that is independent of the total dose. The doubling time or mitotic delay under these conditions has been shown to depend on the dose rate in HeLa, V79 and P388F cells (Mitchell et al., Radiat. Res. 79, 520-536, 1979; Fox and Gilbert, Int. J. Radiat. Biol. 11, 339-347, 1966). Reanalysis of the data for these particular cell lines shows that there is a threshold dose rate for mitotic delay, and that above the threshold there is a linear relationship between the length of mitotic delay and the logarithm of the dose rate which is referred to as the dose-rate response. We have observed the same relationships for L5178Y (LY)-R and LY-S cells exposed to low-dose-rate radiation. The threshold dose rates for LY-R, LY-S and P388F cells are similar (0.01-0.02 Gy/h) and are much lower than for V79 and HeLa cells. The slope of the dose-rate response curve is the greatest for HeLa cells, followed in order by LY-S, V79 and P388F cells, and finally by LY-R cells. The slopes for HeLa and LY-R cells differ by a factor of 35.


Subject(s)
Mitosis/radiation effects , Animals , Cricetinae , Cricetulus , Dose-Response Relationship, Radiation , Flow Cytometry , HeLa Cells , Humans , Leukemia L5178 , Mice , Tumor Cells, Cultured , X-Rays
19.
Radiat Res ; 137(2): 131-44, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8134537

ABSTRACT

In L5178Y mouse lymphoblasts, ionizing radiation-induced mutant frequencies were dramatically higher when the genetic marker analyzed was heterozygous (tk+/tk-) than when hemizygous (tk+/tk0 or hprt+/hprt0). In contrast, base-change mutagens induced similar mutant frequencies at heterozygous and hemizygous loci. These results indicate that the majority of radiation-induced mutants harbor multilocus lesions, and that these mutants are poorly recovered when the target gene is in a hemizygous chromosomal region. Dose-rate dependence of radiation-induced mutant frequency was demonstrated at the heterozygous tk locus but not at the hemizygous hprt locus; in a cell line deficient in the rejoining of DNA double-strand breaks (DSBs), no dose-rate dependence was observed for either locus. The majority of TK-/- mutants, whether spontaneous or induced by X, alpha-particle or UV radiation, or by photosensitization, showed loss of the entire active tk allele. The percentage of TK-/- mutants exhibiting inactivation of galactokinase, encoded by the neighboring gk gene, was high in UV repair-deficient cells exposed to UV radiation and in DNA DSB repair-deficient lines exposed to X radiation. Thus the presence of unrepaired DNA lesions, whether DSBs or pyrimidine dimers, appears to result in an increase in the percentage of mutants harboring multilocus lesions.


Subject(s)
Mutation , Radiation Effects , Animals , Cell Line , DNA Damage , DNA Repair , History, 20th Century , Hypoxanthine Phosphoribosyltransferase/genetics , Mice , Radiology/history , Thymidine Kinase/genetics , Topoisomerase II Inhibitors , United States
20.
Radiat Res ; 136(1): 48-56, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8210338

ABSTRACT

The cytotoxic and mutagenic effects of radon and its progeny were compared in murine lymphoblast L5178Y-R16 cells after exposure at three institutions. The cells were exposed to 222Rn at Case Western Reserve University (CWRU) and Pacific Northwest Laboratories (PNL) and to 212Bi, a decay product of 220Rn, at the University of Chicago (UC). The dose to the cell nucleus was calculated using a dosimetric model which addressed both the contribution of the dose from the radioactivity in the medium and that associated with the cells. The dose-response curves for cell survival showed D0's of 0.30 Gy at CWRU, 0.20 Gy at PNL, 0.37 Gy for chelated 212Bi, and 0.13 Gy for unchelated 212Bi. Induced mutant frequencies at the thymidine kinase locus at the 37% survival level were 1470 x 10(-6) at CWRU, 1518 at PNL, and 2414 x 10(-6) at UC using combined results for chelated and unchelated 212Bi. The variation between institutions was greater than obtained in a previous interlaboratory comparison of the effects of radon on CHO cells. Since less radioactivity was associated with CHO cells than L5178Y cells, we have concluded that the variation between institutions in the case of L5178Y cells is caused by the differences in cell-associated radioactivity and errors related to the measurement of this parameter.


Subject(s)
Cell Survival/radiation effects , Radon Daughters/toxicity , Radon/toxicity , Animals , CHO Cells , Cell Line , Cricetinae , Mice , Mutation , Radiation Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...